THE SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR DAPAGLIFLOZIN EXERTS CARDIOPROTECTIVE EFFECTS AGAINST DOXORUBICIN AND TRASTUZUMAB TOXICITY THROUGH TLR4/MYD88/NF-KB SIGNALING AND NLRP3 INFLAMMASOME PATHWAY

被引:0
|
作者
Maurea, Nicola [1 ]
Quagliariello, Vincenzo [1 ]
Iaffaioli, Rosario Vincenzo [1 ]
De laurentiis, Michelino [1 ]
Botti, Gerardo [1 ]
机构
[1] Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1150-004
引用
收藏
页码:1192 / 1192
页数:1
相关论文
共 49 条
  • [21] Cardioprotective effects of PCSK9 inhibitor evolocumab against doxorubicin-trastuzumab sequential treatments and ipilimumab-induced cardiotoxicity: the role of MyD88/NF-KB/mTORC1 pathways
    Quagliariello, V
    Caronna, A.
    Lombari, C.
    Bonelli, A.
    Conforti, G.
    Botti, G.
    Maurea, N.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3252 - 3252
  • [22] Pepsin Digest of Wheat Gliadin Fraction Increases Production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB Signaling Pathway and an NLRP3 Inflammasome Activation
    Palova-Jelinkova, Lenka
    Danova, Klara
    Drasarova, Hana
    Dvorak, Milos
    Funda, David P.
    Fundova, Petra
    Kotrbova-Kozak, Anna
    Cerna, Marie
    Kamanova, Jana
    Martin, Stefan F.
    Freudenberg, Marina
    Tuckova, Ludmila
    PLOS ONE, 2013, 8 (04):
  • [23] Arctiin Alleviates Atopic Dermatitis Against Inflammation and Pyroptosis Through Suppressing TLR4/MyD88/NF-κB and NLRP3/Caspase-1/ GSDMD Signaling Pathways
    Li, Jingmin
    Du, Xuefei
    Mu, Zhenzhen
    Han, Xiuping
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 8009 - 8026
  • [24] Mild Hypothermia Alleviates CLP-induced Multiple Organ Dysfunction by Mitigating Pyroptosis Through the TLR4/NF-KB/NLRP3 Signaling Pathway
    Jiang, Liangyan
    Li, Xiaorong
    Hu, Juntao
    Tang, Zhanhong
    ARCHIVES OF MEDICAL RESEARCH, 2023, 54 (01) : 7 - 16
  • [25] SGLT2 i Dapagliflozin reduces NF-kB expression in heart and kydneys of preclinical models exposed to doxorubicin through MYd-88 and NLRP3 pathways: an hystological study
    Maurea, N.
    Bisceglia, I.
    Iovine, M.
    Paccone, A.
    Florio, F.
    Grimaldi, S.
    Giordano, V.
    Palma, G.
    Luciano, A.
    Bruzzese, F.
    Zito, F. M.
    Montella, M.
    Franco, R.
    Scherillo, M.
    Quagliariello, V.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [26] Curcumin Represses NLRP3 Inflammasome Activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-Induced Macrophages
    Kong, Fanqi
    Ye, Bozhi
    Cao, Jiatian
    Cai, Xueli
    Lin, Lu
    Huang, Shanjun
    Huang, Weijian
    Huang, Zhouqing
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [27] A Novel Bifunctional Fusion Protein (Anti-IL-17A-sST2) Protects against Acute Liver Failure, Modulating the TLR4/MyD88 Pathway and NLRP3 Inflammasome Activation
    Bai, Yu
    Zhou, Rongrui
    Xie, Xinlei
    Zhu, An
    Nan, Yanyang
    Wu, Tao
    Hu, Xiaozhi
    Cao, Zhonglian
    Ju, Dianwen
    Fan, Jiajun
    BIOMEDICINES, 2024, 12 (05)
  • [28] Huangshui Polysaccharide Exerts Intestinal Barrier Protective Effects through the TLR4/MyD88/NF-κB and MAPK Signaling Pathways in Caco-2 Cells
    Huo, Jiaying
    Pei, Wenhao
    Liu, Guoying
    Sun, Weizheng
    Wu, Jihong
    Huang, Mingquan
    Lu, Wei
    Sun, Jinyuan
    Sun, Baoguo
    FOODS, 2023, 12 (03)
  • [29] Resveratrol pretreatment alleviates NLRP3 inflammasome- mediated cardiomyocyte pyroptosis by targeting TLR4/MyD88/NF-ΚB signaling cascade in coronary microembolization-induced myocardial damage
    Luo, Chang-Jun
    Li, Tao
    Li, Hao-Liang
    Zhou, You
    Li, Lang
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2023, 27 (02): : 143 - 155
  • [30] SGLT-2 INHIBITOR DAPAGLIFLOZIN REDUCES ANTHRACYCLINE-MEDIATED CARDIOMYOPATHY IN PRECLINICAL MODELS THROUGH REDUCTION OF MYOCARDIAL NF-KB, MYD-88 AND NLRP3 EXPRESSION: A BIOCHEMICAL AND HISTOLOGICAL STUDY
    Quagliariello, Vincenzo
    Buccolo, Simona
    Caronna, Antonietta
    Maurea, Carlo
    Paccone, Andrea
    Saviano, Claudia
    Bonelli, Annamaria
    Conforti, Gabriele
    Maurea, Nicola
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24